The upregulation of EGFR leads to autophosphorylation of EGFR, subsequently activating multiple oncogenic signaling cascades, including the Ras/MAPK, PI3K/AKT, and STAT pathways, which collectively accelerate malignant tumor biological functions [18,19]. The gene discussed is AKT1; the disease is neoplasm.